BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Immunoglobulin Allotypes

Below is an extended Immunoglobulin Allotypes research listing. Click here to return to the Immunoglobulin Allotypes main in depth entry.

Recent Publications on Immunoglobulin Allotypes:

Restricted immunoglobulin constant heavy G chain genes in primary immunodeficiencies.
Some primary immunodeficiencies (PIDs) express low serum levels of...
Direct Link
4th September, 2008
Department of Pediatrics and Institute of Clinical Immunology, University
Immunoglobulin allotypes influence antibody responses to mucin 1 in patients with gastric cancer.
There are significant interindividual differences in naturally occurring...
Direct Link
16th August, 2008
Department of Microbiology, Medical University of South Carolina,
Genetic interactions of KIR and G1M immunoglobulin allotypes differ in obese from non-obese individuals with type 2 diabetes.
We analyzed the natural killer cell immunoglobulin-like receptor (KIR)...
Direct Link
18th July, 2008
Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute,
Immunoglobulin constant heavy G subclass chain genes in asthma and allergy.
The IGHG (ImmunoGlobulin constant Heavy G chain) genes are situated close...
Direct Link
6th June, 2008
Department of Pediatrics, University Hospital, Lund University, 221 85,
Immunoglobulin allotypes influence IgG antibody responses to hepatitis C virus envelope proteins E1 and E2.
Immunoglobulin (Ig) GM and KM allotypes-genetic markers of gamma and kappa...
Direct Link
22nd May, 2008
Department of Microbiology and Immunology, Medical University of South
Immunoglobulin allotypes in Southwest Asia: Populations at the Crossroads.
Southwest Asia has a long history of contact with Central Asian and with...
Direct Link
9th May, 2008
Department of Forensic Sciences, George Washington University, Washington,
Fc gamma RIIIa expression is not increased on natural killer cells expressing the Fc gamma RIIIa-158V allotype.
The presence of a valine (V) versus a phenylanaline (F) at position 158 of...
Direct Link
12th March, 2008
EA3853 Immuno-Pharmaco-Genetique des Anticorps therapeutiques, Universite
DP reactive antibody in a zero mismatch renal transplant pair.
This study describes molecular basis for positive B-cell flow crossmatch...
Direct Link
6th March, 2008
Department of Pathology, University of Texas Medical Branch, Galveston,
[A comparison of the therapeutic effects between related donor and unrelated donor allogeneic hematopoietic stem cell transplantation in treatment of leukemia] 6th November, 2007
Department of Hematology, Nanfang Hospital, Southern Medical University,
Subversion of B lymphocyte tolerance by hydralazine, a potential mechanism for drug-induced lupus.
Accumulating evidence indicates that epigenetic alterations contribute to...
Direct Link
18th October, 2007
Institut National de la Sante et de la Recherche Medicale, U430,
Ig allotypic inclusion does not prevent B cell development or response. 20th September, 2007
Integrated Department of Immunology, National Jewish Medical and Research
GM and KM immunoglobulin allotypes in the Galician population: new insights into the peopling of the Iberian Peninsula.
BACKGROUND: The current genetic structure of Iberian populations has...
Direct Link
10th August, 2007
Departamento de Zoologia y Antropologia Fisica, Facultad de Biologia,
Incomplete assembly of IgA2m(2) in Chinese hamster ovary cells.
Myeloma and Chinese hamster ovary (CHO) cells are frequently used for the...
Direct Link
1st August, 2007
Department of Microbiology, Immunology and Molecular Genetics and the
Immunogenicity of autologous immunoglobulins: principles and practices.
The immunogenicity of immunoglobulin idiotypes in syngeneic systems is a...
Direct Link
12th July, 2007
Department of Antibody Engineering, Center of Molecular Immunology, P.O.
Delayed severe HPA-5b neonatal alloimmune thrombocytopenia: a case report.
OBJECTIVE: To compare the therapeutic effect for leukemia between related...
Direct Link
16th May, 2007
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional